| Literature DB >> 35684442 |
Motlalepula Gilbert Matsabisa1, Asis Bala1,2, Satyajit Tripathy1, Michelle Mogomane Digashu1, Fanie Rautenbach3, Barsha Dassarma1, Joseph Omorogiuwa Erhabor1, Fernao Castro Braga4, Pulok Kumar Mukherjee5, Minke Tang6, Youngmin Kang7.
Abstract
Background: This study comparatively assessed seven indigenous traditional tea plants on several attributes that included antioxidant, nutritional, caffeine contents, and cyclooxygenase activity. Methodology: Nutritional content of all tea plants were determined for energy, fat, carbohydrates, total sugars, dietary fiber and amino acids. Antioxidant potential and the antioxidant potentiating secondary metabolites were also measured and compared. Further, we investigated the tea plants for any role they would have on cyclooxygenase (COX) activity on cobalt chloride (CoCl2) induced human glioma cell lines (U87MG).Entities:
Keywords: antioxidant capacity; commercial tea; cox activity; indigenous tea; nutritional content
Mesh:
Substances:
Year: 2022 PMID: 35684442 PMCID: PMC9181930 DOI: 10.3390/molecules27113505
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.927
Selected indigenous South African indigenous tea plants with their code names, botanical names, local names, uses and geographical coordinates.
| S/N (Plant Codes) | Botanical Names | Family Names | Local Names | Common Names | Uses | Geographical Coordinates | References |
|---|---|---|---|---|---|---|---|
| (DT-01) | Verbenaceae | iNzinziniba (Xhosa); uMsuzwane. uMswazi (Zulu). Koorsbossie, Beukesbossie, Lemoenbossie (Afrikaans) | fever tea, lemon bush | herbal health tea to treat colds, cough, fever or malaria, wounds, repelling mosquitos, diarrhoea, chest pains, bronchitis, and asthma; widely sold as herbal tea in Botswana, South Africa. and Zimbabwe; In South Africa used in the treatment of livestock ailments; Isolated (E)-2(3)-tagetenone epoxide from |
| [ | |
| (DT-02) | Verbenaceae | In Malawi and Zimbabwe to treat coughs, asthma, fever, and headaches; in Botswana as a soothing and relaxing tea; essential oils have fungistatic activity against |
| [ | |||
| (DT-03) | Under evaluation | Under evaluation | Iti ye Hlathi (Local name of plant in Uitenhage in EC Province of South Africa) | Locals in Uitenhage area. Eastern Cape used it as a beverage (with or without sugar and milk). THPs use the tea to treat and manage swollen legs and feet, body itches and body pains. Also used to boost energy; to clean the womb, kidneys and blood, uretic and an antihypertensive. |
| Our Lab report (not published) | |
| (DT-04) | Scrophulariaceae | Witolien (Afrikaans). unGqeba (Xhosa). iGqeba-elimhlope (Zulu) | False olive | To treat high blood pressure. chest pains, coughs, diabetes, colds, and tuberculosis; anti-inflammatory, anti-malaria, antioxidant, and antibacterial activities; anti-microbial acetylcholinesterase inhibitory activities; eye infections and neurodegenerative diseases; antiplasmodial activity, inhibition of nitric oxide (NO) overproduction, and anti-proliferative activity | [ | ||
| (DT-05) | Verbenaceae | Hawu Hawu by amaXhosa people of Ntshatshongo | bushy lippia, honey herb | As natural sweetener; to treat various diseases associated with bronchi; to manage cough and an emmanagogue; asthma and chronic bronchitis; has a minty taste and do not cause tooth decay |
| [ | |
| (DT-06) | Myrothamnaceae | Uvukakwabafile (isiZulu). Bergboegoe (Afrikaans) | resurrection plant | Nama people use the leaf extract in wound healing, asthma and chest ailments; Also for infectious and respiratory diseases, inflammation, heart, and kidney ailments; to treat chest pains, coughs, epilepsy, and mental disorders; As tonic and skin moisturizer; antidiabetic and antioxidant activity; potent antimicrobial activity; antioxidant, anticancer, antiviral, antidiabetic, anti-inflammatory, antiarthritic, antiulcer and antimicrobial properties |
| [ | |
| (DT-07) |
| Euphorbiaceae | Bergboegoe. iLabele. iNkubathi | Lavender croton | anti-microbial activity; sexually transmitted diseases; antiplatelet aggregation. anti-proliferative activities and antiplasmodial activities; influenza, colds, fevers; antioxidant and acetylcholinesterase inhibitory activity |
| [ |
Figure 1Geographical origins of the Indigenous tea plants-infusions.
Indigenous tea plants (Code: DT-01 to DT-07) from different regions of South Africa. Voucher specimen. Trade names and infusion extractabilities.
| Indigenous Tea Plants (Infusions) | |||||
|---|---|---|---|---|---|
| Code | Plant Species | Botanical Name | Voucher Specimen No. | Trade Name | Water Extraction Yield (%) |
| DT-01 | Inzinziniba |
| MGM005 | Zinibar | 7.36 |
| DT-02 | Mosukujane |
| MGM0012 | Mosukujane | 15.48 |
| DT-03 | Iti Yehlathi |
| MGM008 | Tinar | 11.4 |
| DT-04 | Igqhange |
| MGM0015 | Gancair | 7.1 |
| DT-05 | Hawu Hawu |
| MGM0016 | Haw Haw | 12.22 |
| DT-06 | Moritela Tshwene |
| MGM0011 | Resurrection bush | 14.08 |
| DT-07 | Moologa | MGM009 | Moologa | 14.74 | |
Figure 2Antioxidant capacities of all the tea plants. (A) FRAP; (B) TEAC; and (C) ORAC levels. n = 3.
Nutritional content of all the tea plants. (A) indigenous tea plants. (B) Nutritional and nutraceutical properties of all the tea samples.
|
| |||||||||
|
|
|
|
| ||||||
|
|
|
|
|
|
|
| |||
| Dry matter | ASM 013 | % | 89.56 | 92.68 | 91.02 | 94.51 | 91.26 | 91.49 | 93.46 |
| Moisture | ASM 013 | % | 10.41 | 7.32 | 8.98 | 5.49 | 8.74 | 8.51 | 6.54 |
| Ash | ASM 048 | % | 9.22 | 5.13 | 13.14 | 3.65 | 9.56 | 14.20 | 3.22 |
| Protein (N × 6.25) | ASM 078 | % | 14.44 | 12.80 | 14.12 | 6.15 | 10.09 | 17.60 | 9.26 |
| Fat (Ether extraction) | ASM 044 | % | 1.33 | 3.43 | 2.84 | 2.90 | 2.83 | 3.19 | 3.81 |
| Carbohydrates (Calculated) | ASM 075 | % | 64.60 | 71.32 | 60.92 | 81.81 | 68.78 | 56.50 | 77.17 |
| Energy (Calculated) | ASM 076 | kJ/100 g | 448 | 583 | 462 | 529 | 586 | 506 | 771 |
| Calcium | ASM 042 | % | 1.49 | 0.89 | 2.13 | 1.06 | 1.29 | 1.69 | 0.59 |
| Total Non-structural Carbohydrates | ASM 074 | % | 9.03 | 14.03 | 6.85 | 18.67 | 18.25 | 5.21 | 27.81 |
| Water Soluble Carbohydrates | NSA | % | 0.04 | 0.05 | 0.03 | 0.10 | 0.10 | 0.02 | 0.16 |
| Starch | NSA | % | 0.00 | 0.00 | 0.00 | 0.00 | 1.17 | 0.00 | 0.00 |
| Total sugars | NSA | % | 0.03 | 14.03 | 6.85 | 18.67 | 17.08 | 5.21 | 27.81 |
| Glucose | NSA | g/100 g | 0.00 | 0.00 | 0.00 | 0.00 | 2.71 | 0.00 | 4.59 |
| Fructose | NSA | g/100 g | 0.00 | 0.00 | 0.00 | 0.00 | 2.93 | 0.00 | 2.94 |
| Sucrose | NSA | g/100 g | 0.00 | 0.00 | 0.00 | 2.53 | 2.77 | 0.00 | 0.00 |
| Maltose | NSA | g/100 g | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Lactose | NSA | g/100 g | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2.84 |
| Dietary Fibre (Total) | ASM 070 | % | 61.86 | 55.09 | 43.29 | 50.29 | 46.40 | 48.77 | 33.40 |
| Cysteine | NSA | g/100 g | 0.22 | 0.26 | 0.24 | 0.16 | 0.19 | 0.34 | 0.21 |
| Tryptophan | ASM 022 | g/100 g | 0.06 | 0.05 | 0.06 | 0.04 | 0.04 | 0.10 | 0.07 |
| Arginine | ASM 021 | g/100 g | 0.74 | 0.65 | 0.83 | 0.35 | 0.56 | 1.01 | 0.58 |
| Serine | ASM 021 | g/100 g | 0.56 | 0.45 | 0.65 | 0.32 | 0.49 | 0.90 | 0.45 |
| Aspartic acid | ASM 021 | g/100 g | 1.25 | 0.87 | 1.32 | 0.54 | 0.83 | 1.68 | 0.80 |
| Glutamic acid | ASM 021 | g/100 g | 1.34 | 1.20 | 1.35 | 0.58 | 0.99 | 1.82 | 0.96 |
| Glycine | ASM 021 | g/100 g | 0.62 | 0.47 | 0.71 | 0.33 | 0.50 | 0.96 | 0.48 |
| Threonine | ASM 021 | g/100 g | 0.53 | 0.41 | 0.60 | 0.27 | 0.42 | 0.80 | 0.41 |
| Alanine | ASM 021 | g/100 g | 0.66 | 0.50 | 0.73 | 0.32 | 0.51 | 0.96 | 0.50 |
| Tyrosine | ASM 021 | g/100 g | 0.49 | 0.36 | 0.53 | 0.24 | 0.40 | 0.64 | 0.34 |
| Proline | ASM 021 | g/100 g | 0.75 | 0.69 | 0.64 | 0.48 | 1.26 | 0.87 | 0.45 |
| HO-Proline | ASM 021 | g/100 g | 0.10 | 0.13 | 0.16 | 0.07 | 0.08 | 0.20 | 0.10 |
| Methionine | ASM 021 | g/100 g | 0.18 | 0.13 | 0.18 | 0.08 | 0.14 | 0.21 | 0.14 |
| Valine | ASM 021 | g/100 g | 0.70 | 0.51 | 0.76 | 0.34 | 0.53 | 0.96 | 0.49 |
| Phenylalanine | ASM 021 | g/100 g | 0.66 | 0.54 | 0.73 | 0.31 | 0.48 | 0.94 | 0.43 |
| Isoleucine | ASM 021 | g/100 g | 0.58 | 0.43 | 0.61 | 0.29 | 0.44 | 0.78 | 0.41 |
| Leucine | ASM 021 | g/100 g | 0.98 | 0.74 | 1.10 | 0.49 | 0.75 | 1.40 | 0.73 |
| Histidine | ASM 021 | g/100 g | 0.76 | 0.46 | 0.50 | 0.35 | 0.57 | 0.78 | 0.29 |
| Lysine | ASM 021 | g/100 g | 0.76 | 0.66 | 0.62 | 0.35 | 0.68 | 0.85 | 0.57 |
|
| |||||||||
|
|
|
|
|
|
|
| |||
| DT-01 | 0.25 | 99.75 | 0.01 | 0.78 | 29 | ||||
| DT-02 | 0.19 | 99.81 | 0.01 | 1.03 | 38 | ||||
| DT-03 |
| 0.35 | 99.65 | 0.01 | 0.79 | 29 | |||
| DT-04 | 0.26 | 99.74 | 0.01 | 1.01 | 37 | ||||
| DT-05 | 0.11 | 99.89 | 0.01 | 1.06 | 39 | ||||
| DT-06 | 0.38 | 99.64 | 0.01 | 0.95 | 35 | ||||
| DT-07 | 0.25 | 99.75 | 0.01 | 0.71 | 26 | ||||
Figure 3Evaluation of antioxidant compounds in all the tea plants. (A) Estimation of polyphenols equivalent to gallic acid; (B) estimation of flavanols equivalent to catechin; (C) total flavonoid content (TFC) estimation; (D) estimation of flavonols equivalent to quercetin.
Figure 4Cytotoxicity and cell proliferation on normal human Chang Liver cells over 24 h exposure of tested indigenous tea plants with trade names ((A) Haw; (B) Gancair; (C) Moologa; (D) Mosukujane; (E) Resurrection bush; (F) Tinar; (G) Zinibar. (H) Positive controls).
Figure 5Cytotoxicity and cell proliferation on normal human HEK293 liver cells over 24 h exposure of tested indigenous tea plants with trade names ((A) Haw Haw; (B) Gancair; (C) Moologa; (D) Mosukujane; (E) Resurrection bush; (F) Tinar; (G) Zinibar. (H) Positive controls).
Figure 6(a) Graphical presentation represents the u87 MG cell number after treatment with tea plants extracts (DT01–DT07) at 250 µg/mL for 24 h and 48 h. Values are expressed as mean ± SEM, n = 3. * Significant difference (p < 0.05) compared to 24 h control group. # Significant difference (p < 0.05) compared to 48 h control group. (b) Light microscopic images of cell proliferation of Control, DT01, DT02, and DT04-treated groups at different times.
Figure 7Graphical presentation represents COX inhibition activity in CoCl2 (100µM) exposed U87 MG cells after treatment with tea plants extracts (DT01, DT02, and DT04) at 50, 100, and 250 µg/mL for 24 h. Here, celecoxib was used at 100 µM. Values are expressed as mean ± SEM, n = 3. * Significant difference (p < 0.05) compared to only CoCl2 group.